BLRX
Price
$0.20
Change
-$0.01 (-4.76%)
Updated
Dec 18, 04:59 PM (EDT)
98 days until earnings call
PYXS
Price
$1.53
Change
-$0.10 (-6.13%)
Updated
Dec 18, 04:28 PM (EDT)
92 days until earnings call
Ad is loading...

BLRX vs PYXS

Header iconBLRX vs PYXS Comparison
Open Charts BLRX vs PYXSBanner chart's image
BioLineRx
Price$0.20
Change-$0.01 (-4.76%)
Volume$23.97K
CapitalizationN/A
Pyxis Oncology
Price$1.53
Change-$0.10 (-6.13%)
Volume$7.1K
CapitalizationN/A
BLRX vs PYXS Comparison Chart
Loading...
BLRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PYXS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BLRX vs. PYXS commentary
Dec 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BLRX is a Hold and PYXS is a Hold.

COMPARISON
Comparison
Dec 19, 2024
Stock price -- (BLRX: $0.21 vs. PYXS: $1.63)
Brand notoriety: BLRX and PYXS are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BLRX: 67% vs. PYXS: 54%
Market capitalization -- BLRX: $22.49M vs. PYXS: $96.93M
BLRX [@Biotechnology] is valued at $22.49M. PYXS’s [@Biotechnology] market capitalization is $96.93M. The market cap for tickers in the [@Biotechnology] industry ranges from $486.73B to $0. The average market capitalization across the [@Biotechnology] industry is $2.67B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BLRX’s FA Score shows that 1 FA rating(s) are green whilePYXS’s FA Score has 1 green FA rating(s).

  • BLRX’s FA Score: 1 green, 4 red.
  • PYXS’s FA Score: 1 green, 4 red.
According to our system of comparison, both BLRX and PYXS are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BLRX’s TA Score shows that 4 TA indicator(s) are bullish while PYXS’s TA Score has 5 bullish TA indicator(s).

  • BLRX’s TA Score: 4 bullish, 4 bearish.
  • PYXS’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, both BLRX and PYXS are a good buy in the short-term.

Price Growth

BLRX (@Biotechnology) experienced а -12.41% price change this week, while PYXS (@Biotechnology) price change was -2.98% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -6.67%. For the same industry, the average monthly price growth was -1.92%, and the average quarterly price growth was +0.65%.

Reported Earning Dates

BLRX is expected to report earnings on Mar 26, 2025.

PYXS is expected to report earnings on Mar 20, 2025.

Industries' Descriptions

@Biotechnology (-6.67% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PYXS($96.9M) has a higher market cap than BLRX($19.3M). PYXS YTD gains are higher at: -9.444 vs. BLRX (-86.688). BLRX has higher annual earnings (EBITDA): -24.93M vs. PYXS (-64.04M). PYXS has more cash in the bank: 145M vs. BLRX (40.1M). PYXS has less debt than BLRX: PYXS (20.5M) vs BLRX (31.3M). BLRX has higher revenues than PYXS: BLRX (17M) vs PYXS (16.1M).
BLRXPYXSBLRX / PYXS
Capitalization19.3M96.9M20%
EBITDA-24.93M-64.04M39%
Gain YTD-86.688-9.444918%
P/E RatioN/AN/A-
Revenue17M16.1M106%
Total Cash40.1M145M28%
Total Debt31.3M20.5M153%
FUNDAMENTALS RATINGS
BLRX: Fundamental Ratings
BLRX
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
30
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
98
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BLRXPYXS
RSI
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
71%
Bullish Trend 2 days ago
84%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
85%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
81%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
88%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
89%
Advances
ODDS (%)
Bullish Trend 20 days ago
80%
Bullish Trend 3 days ago
81%
Declines
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 7 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
77%
Bullish Trend 2 days ago
67%
Aroon
ODDS (%)
N/A
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Ad is loading...
BLRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PYXS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ALCO26.240.47
+1.82%
Alico
LC17.79-0.12
-0.67%
LendingClub Corp
PCH41.41-0.57
-1.36%
PotlatchDeltic Corp
SBAC208.99-3.29
-1.55%
SBA Communications Corp
INKT0.54-0.04
-7.12%
MiNK Therapeutics

BLRX and

Correlation & Price change

A.I.dvisor indicates that over the last year, BLRX has been loosely correlated with KURA. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if BLRX jumps, then KURA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BLRX
1D Price
Change %
BLRX100%
-2.34%
KURA - BLRX
34%
Loosely correlated
-2.36%
DWTX - BLRX
33%
Loosely correlated
-4.49%
PYXS - BLRX
31%
Poorly correlated
-2.98%
INSM - BLRX
30%
Poorly correlated
+0.63%
SNPX - BLRX
30%
Poorly correlated
-1.99%
More

PYXS and

Correlation & Price change

A.I.dvisor indicates that over the last year, PYXS has been loosely correlated with KURA. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if PYXS jumps, then KURA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PYXS
1D Price
Change %
PYXS100%
-2.98%
KURA - PYXS
44%
Loosely correlated
-2.36%
CTMX - PYXS
39%
Loosely correlated
-1.74%
BEAM - PYXS
34%
Loosely correlated
-1.21%
DNLI - PYXS
34%
Loosely correlated
-0.30%
ABOS - PYXS
33%
Loosely correlated
-0.51%
More